Nightingale Research Logo
Have had Heart Attack, Stroke or Kidney Disease with Overweight
Have had Heart Attack, Stroke or Kidney Disease with Overweight
NOW RECRUITING
-
Adelaide SA

Effect of Orforglipron on patients with established CVD and/or CKD.

  • Age > 50 years
  • BMI > 25 kg/m²
  • Oral tablet daily
  • Not taking Ozempic/Mounjaro
Information for Practitioners
  • Screening bloods
  • Fundus photography for diabetic participants
  • Previous MI/CVA/PVD or CKD